Results for "KSS"
Conditions Encyclopedia Entry 1777262884
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of MM can vary widely, depending on the specific type of disorder and the severity of the mutation. Mitochondrial myopathies are often inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. However, some types of MM can be inherited in an **autosomal recessive** pattern, requiring two copies of the mutated gene to cause the disorder. The disorders can also occur spontaneously, without a family history. The symptoms of MM can be diverse and may include muscle weakness, fatigue, exercise intolerance, and muscle pain. In some cases, the disorders can lead to more severe symptoms, such as seizures, vision loss, and hearing loss. The disorders can also affect the brain, leading to cognitive impairment, dementia, and other neurological problems. ### History/Background Mitochondrial myopathies were first identified in the 1960s, when researchers discovered that some patients with muscle weakness and other symptoms had abnormal mitochondria in their muscle cells. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying these disorders. In the 1980s, researchers discovered that the disorders were caused by mutations in the mitochondrial DNA. This was a significant breakthrough, as it provided a clear understanding of the genetic basis of the disorders. Since then, numerous studies have been conducted to identify the specific genes and mutations responsible for the disorders. ### Key Information Mitochondrial myopathies are a group of disorders that affect the mitochondria, the energy-producing structures within cells. The disorders are caused by mutations in the mitochondrial DNA and can affect various parts of the body, including the muscles, brain, and other organs. There are several types of MM, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: This is a severe disorder that affects the brain, muscles, and other organs. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: This disorder affects the muscles and brain, causing seizures, muscle weakness, and other symptoms. * **Kearns-Sayre syndrome (KSS)**: This disorder affects the muscles, brain, and other organs, causing symptoms such as muscle weakness, vision loss, and heart problems. ### Significance Mitochondrial myopathies are a group of rare genetic disorders that can have a significant impact on patients and their families. The disorders can cause a range of symptoms, from mild muscle weakness to severe neurological problems. Understanding the genetic and molecular mechanisms underlying MM is crucial for developing effective treatments and improving patient outcomes. Researchers are working to identify new genes and mutations responsible for the disorders, as well as developing new therapies to target the underlying causes of the disorders. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first identified) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, muscle weakness, exercise intolerance, muscle pain, seizures, vision loss, hearing loss, cognitive impairment, dementia, neurological problems, MELAS, MERRF, KSS, Kearns-Sayre syndrome.
Health & MedicineConditions Encyclopedia Entry 1776700926
** **Mitochondrial Myopathies** are a group of rare genetic disorders characterized by muscle weakness, fatigue, and other systemic symptoms due to mutations in the mitochondrial DNA. **CONTENT:** ## Overview Mitochondrial myopathies are a diverse group of disorders that affect the mitochondria, the energy-producing structures within cells. These conditions are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various systems in the body, including the muscles, nervous system, and other organs. Symptoms can range from mild to severe and may include muscle weakness, fatigue, exercise intolerance, and other systemic symptoms. Mitochondrial myopathies are often inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be **sporadic**, occurring without a family history of the condition. The diagnosis of mitochondrial myopathies can be challenging, as the symptoms may be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to recognize the importance of mitochondrial function in muscle disease. However, it wasn't until the 1980s that the genetic basis of these conditions was fully understood. Since then, numerous studies have shed light on the molecular mechanisms underlying mitochondrial myopathies, leading to a better understanding of these complex disorders. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which can affect various genes involved in energy production. Some of the most common forms of mitochondrial myopathies include: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: A condition characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: A condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsy. * **Kearns-Sayre syndrome (KSS)**: A condition characterized by muscle weakness, heart block, and pigmentary retinopathy. Other forms of mitochondrial myopathies include **Leigh syndrome**, **NARP syndrome**, and **Pearson syndrome**, among others. ## Significance Mitochondrial myopathies are rare but significant conditions that can have a profound impact on patients and their families. These conditions can affect various aspects of daily life, including physical function, cognitive abilities, and overall quality of life. While there is currently no cure for mitochondrial myopathies, various treatments are available to manage symptoms and improve quality of life. **Early diagnosis** and **genetic counseling** are essential for individuals and families affected by mitochondrial myopathies. Genetic testing can help identify the underlying mutation and provide a more accurate diagnosis. Support groups and online resources can also provide valuable information and emotional support for patients and their families. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first descriptions) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting muscle function and energy production **TAGS:** Mitochondrial myopathies, genetic disorders, muscle disease, energy production, mitochondrial DNA, autosomal dominant, sporadic, MELAS, MERRF, KSS, Leigh syndrome, NARP syndrome, Pearson syndrome, genetic counseling, support groups.
Health & MedicineConditions Encyclopedia Entry 1776279669
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a collection of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by muscle weakness, fatigue, and other symptoms related to impaired energy production. Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. This unique genetic makeup makes MM distinct from other myopathies and requires specialized diagnosis and treatment. Mitochondrial myopathies can affect people of all ages, from infants to adults. The symptoms of MM can vary widely, but common signs include muscle weakness, particularly in the arms and legs, as well as muscle cramps, pain, and stiffness. Some individuals may experience vision problems, hearing loss, or developmental delays. In severe cases, MM can lead to life-threatening complications, such as respiratory failure or cardiac arrest. ## History/Background The study of mitochondrial myopathies began in the 1960s, when researchers first identified the link between mitochondrial DNA mutations and certain diseases. Since then, significant advances have been made in understanding the genetic basis of MM and developing diagnostic tools. In the 1980s, the first mitochondrial DNA mutations were identified, and in the 1990s, the first genetic tests for MM were developed. Today, researchers continue to investigate the causes and consequences of mitochondrial myopathies, with a focus on developing effective treatments and improving patient outcomes. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. There are over 200 known mitochondrial DNA mutations that can cause MM, with some mutations more common than others. The most common type of MM is **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**, which affects approximately 1 in 5,000 people. Other types of MM include **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)** and **Kearns-Sayre Syndrome (KSS)**. Diagnosing MM can be challenging, as the symptoms can be similar to those of other myopathies. A definitive diagnosis typically requires genetic testing, which involves analyzing the mitochondrial DNA for mutations. Treatment for MM is focused on managing symptoms and improving quality of life. This may involve physical therapy, speech therapy, and other forms of rehabilitation. In some cases, medications may be prescribed to alleviate symptoms, such as pain or muscle spasms. ## Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. By studying MM, researchers can gain insights into the mechanisms underlying energy production and the consequences of impaired energy metabolism. This knowledge can lead to the development of new treatments for a range of diseases, from cancer to neurodegenerative disorders. Furthermore, the study of MM has important implications for our understanding of the genetic basis of disease and the role of mitochondrial DNA in human health. INFOBOX: - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first identified) - Location: Global - Known For: Rare genetic disorders affecting mitochondrial energy production TAGS: Mitochondrial myopathies, genetic disorders, muscle weakness, fatigue, energy production, mitochondrial DNA, MELAS, MERRF, KSS, Kearns-Sayre Syndrome.
Health & MedicineConditions Encyclopedia Entry 1780319348
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms and severity of MM vary widely among individuals, making diagnosis and treatment challenging. Mitochondrial myopathies are characterized by a range of symptoms, including muscle weakness, fatigue, exercise intolerance, and muscle pain. Some individuals may also experience neurological symptoms, such as seizures, vision loss, and hearing loss. In severe cases, MM can lead to life-threatening complications, such as heart failure, respiratory failure, and kidney failure. ### History/Background The first reported case of mitochondrial myopathy was in 1962, when a British neurologist, Dr. Keith Morgan, described a patient with a rare muscle disorder. However, it wasn't until the 1980s that the genetic basis of MM was discovered. Researchers identified mutations in the mitochondrial DNA as the cause of these disorders. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying MM. ### Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. These mutations affect the production of energy within cells, leading to a range of symptoms and complications. There are several types of MM, including: * **Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: A severe form of MM characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: A type of MM characterized by muscle weakness, seizures, and vision loss. * **Kearns-Sayre Syndrome (KSS)**: A rare form of MM characterized by muscle weakness, vision loss, and heart problems. ### Significance Mitochondrial myopathies are rare disorders, affecting approximately 1 in 5,000 people worldwide. However, they can have a significant impact on individuals and families affected by these disorders. Early diagnosis and treatment can improve the quality of life for individuals with MM, but there is currently no cure for these disorders. Research into mitochondrial myopathies has led to a greater understanding of the genetic and molecular mechanisms underlying these disorders. This knowledge has also led to the development of new treatments and therapies, such as gene therapy and mitochondrial-targeted antioxidants. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, muscle weakness, fatigue, exercise intolerance, muscle pain, neurological symptoms, seizures, vision loss, hearing loss, heart failure, respiratory failure, kidney failure, MELAS, MERRF, KSS, gene therapy, mitochondrial-targeted antioxidants.
Health & MedicineConditions Encyclopedia Entry 1778906644
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of mitochondrial myopathies can vary widely, but often include muscle weakness, fatigue, and other neurological problems. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. In some cases, the condition can be caused by a new mutation, rather than an inherited one. The exact prevalence of mitochondrial myopathies is unknown, but it is estimated to affect about 1 in 5,000 to 1 in 10,000 people. ## History/Background The first cases of mitochondrial myopathies were described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of scientists led by Dr. Doug Wallace discovered that mitochondrial myopathies were caused by mutations in the mitochondrial DNA. This discovery revolutionized the field of genetics and paved the way for the development of genetic testing for these disorders. ## Key Information There are several types of mitochondrial myopathies, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: a condition characterized by muscle weakness, seizures, and episodes of lactic acidosis. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: a condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle tissue. * **Kearns-Sayre syndrome (KSS)**: a condition characterized by muscle weakness, heart problems, and vision loss. * **Leigh syndrome**: a condition characterized by muscle weakness, seizures, and brain damage. The symptoms of mitochondrial myopathies can vary widely, but often include: * Muscle weakness and fatigue * Neurological problems, such as seizures and vision loss * Cardiac problems, such as heart failure * Gastrointestinal problems, such as diarrhea and abdominal pain * Endocrine problems, such as diabetes and thyroid problems ## Significance Mitochondrial myopathies are a significant cause of morbidity and mortality in affected individuals. The symptoms of these disorders can be severe and debilitating, and there is currently no cure. However, with proper management and treatment, individuals with mitochondrial myopathies can lead active and fulfilling lives. ## INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic Disorders - **Date:** 1960s (first cases described) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria ## TAGS: Genetic Disorders, Mitochondrial Myopathies, MELAS, MERRF, KSS, Leigh Syndrome, Muscle Weakness, Neurological Problems
Health & MedicineConditions Encyclopedia Entry 1779253564
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders occur when there is a mutation in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of mitochondrial myopathies can vary widely, but often include muscle weakness, fatigue, and neurological problems. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition, and it is passed down from the mother. The disorders are relatively rare, affecting approximately 1 in 5,000 people worldwide. However, the exact prevalence of mitochondrial myopathies is difficult to determine due to the lack of a centralized registry and the varying severity of the conditions. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers discovered that certain types of muscle disease were caused by mutations in the mitochondrial DNA. However, it wasn't until the 1980s that the genetic basis of these disorders was fully understood. Since then, numerous studies have been conducted to better understand the causes, symptoms, and treatment options for mitochondrial myopathies. ### Key Information Mitochondrial myopathies are a heterogeneous group of disorders, and there are several types, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: A disorder that affects the brain, muscles, and other organs, causing symptoms such as seizures, muscle weakness, and stroke-like episodes. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: A disorder that affects the brain and muscles, causing symptoms such as seizures, muscle weakness, and ragged-red fibers in muscle tissue. * **Kearns-Sayre syndrome (KSS)**: A disorder that affects the muscles, brain, and other organs, causing symptoms such as muscle weakness, vision loss, and heart problems. The diagnosis of mitochondrial myopathies is often challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. The disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these conditions. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, autosomal dominant, maternal inheritance, muscle weakness, fatigue, neurological problems, MELAS, MERRF, KSS, Kearns-Sayre syndrome.
Health & MedicineConditions Encyclopedia Entry 1778127065
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nerves, and brain. The symptoms of these disorders can vary widely, but often include muscle weakness, fatigue, and pain. Mitochondrial myopathies are typically inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the disorder, and the disorder is passed down from mother to child. The disorders can also be caused by **de novo mutations**, which occur spontaneously during the formation of egg or sperm cells. ## History/Background The first description of mitochondrial myopathies dates back to the 1960s, when a group of researchers discovered a rare disorder that affected the muscles of a young woman. Since then, numerous cases have been reported, and the disorders have been classified into several subtypes based on their genetic and clinical characteristics. In the 1980s, researchers discovered that mitochondrial myopathies were caused by mutations in the mitochondrial DNA. This breakthrough led to a greater understanding of the disorders and their underlying mechanisms. Today, mitochondrial myopathies are recognized as a distinct group of disorders, and researchers continue to study their causes, symptoms, and treatment options. ## Key Information **Key Facts:** * Mitochondrial myopathies are caused by mutations in the mitochondrial DNA. * The disorders can affect various parts of the body, including the muscles, nerves, and brain. * Symptoms can vary widely, but often include muscle weakness, fatigue, and pain. * The disorders are typically inherited in an autosomal dominant or maternal inheritance pattern. * De novo mutations can also cause the disorders. **Subtypes:** * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a subtype characterized by seizures, muscle weakness, and lactic acidosis. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a subtype characterized by seizures, muscle weakness, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre Syndrome (KSS)**: a subtype characterized by muscle weakness, heart block, and pigmentary retinopathy. ## Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. The disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these disorders. **Impact:** * Mitochondrial myopathies have led to a greater understanding of mitochondrial function and its role in human disease. * The disorders have also led to the development of new diagnostic and therapeutic strategies for mitochondrial disorders. * Research on mitochondrial myopathies has implications for the treatment of other disorders, including cancer and neurodegenerative diseases. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first description) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria TAGS: Mitochondrial myopathies, genetic disorders, mitochondrial DNA, autosomal dominant, maternal inheritance, de novo mutations, muscle weakness, fatigue, pain, MELAS, MERRF, KSS, Kearns-Sayre Syndrome.
Health & MedicineConditions Encyclopedia Entry 1777485186
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of mitochondrial myopathies can vary widely depending on the specific disorder and the individual affected. Mitochondrial myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. The disorders are typically characterized by progressive muscle weakness, fatigue, and other systemic symptoms. In some cases, mitochondrial myopathies can be associated with other conditions, such as diabetes, seizures, and vision problems. ### History/Background Mitochondrial myopathies were first described in the 1960s, when researchers began to understand the role of mitochondria in energy production. The first cases of mitochondrial myopathies were reported in the 1970s, and since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying these disorders. One of the key milestones in the history of mitochondrial myopathies was the discovery of the first mitochondrial DNA mutation in 1988. This discovery led to a greater understanding of the genetic basis of mitochondrial myopathies and paved the way for the development of genetic testing for these disorders. ### Key Information Mitochondrial myopathies are a diverse group of disorders, and there are over 150 known mitochondrial DNA mutations that can cause these conditions. Some of the most common mitochondrial myopathies include: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: This disorder is characterized by progressive muscle weakness, seizures, and other systemic symptoms. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: This disorder is characterized by muscle weakness, seizures, and other systemic symptoms. * **Kearns-Sayre Syndrome (KSS)**: This disorder is characterized by progressive muscle weakness, vision problems, and other systemic symptoms. ### Significance Mitochondrial myopathies are significant because they can have a profound impact on the quality of life of affected individuals. These disorders can cause progressive muscle weakness, fatigue, and other systemic symptoms, which can make everyday activities challenging. In some cases, mitochondrial myopathies can be associated with other conditions, such as diabetes, seizures, and vision problems. The significance of mitochondrial myopathies extends beyond the individual affected. These disorders can have a significant impact on families and communities, particularly in cases where the disorder is inherited. Genetic testing and counseling can help families understand the risk of passing on the disorder to future generations. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Genetic Disorders - **Date:** 1960s (first described) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, fatigue, and other systemic symptoms **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Systemic Symptoms, MELAS, MERRF, KSS, Mitochondrial DNA Mutations, Genetic Testing, Counseling
Health & MedicineConditions Encyclopedia Entry 1780689126
** This article discusses **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by progressive muscle weakness, wasting, and other systemic symptoms. MM are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. The symptoms of MM can vary widely, depending on the specific mutation and the affected individual. Common symptoms include muscle weakness, fatigue, and pain, as well as vision and hearing loss, and developmental delays. Mitochondrial Myopathies are often classified into several subtypes, including: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a severe subtype characterized by recurrent episodes of stroke-like symptoms, lactic acidosis, and other systemic symptoms. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a subtype characterized by myoclonic seizures, muscle weakness, and other systemic symptoms. * **Kearns-Sayre Syndrome (KSS)**: a subtype characterized by progressive external ophthalmoplegia, heart block, and other systemic symptoms. ## History/Background The first reported case of Mitochondrial Myopathies dates back to 1963, when a British neurologist, **William Kearns**, described a patient with progressive external ophthalmoplegia and other systemic symptoms. However, it wasn't until the 1980s that the genetic basis of MM was identified, with the discovery of mutations in the mitochondrial DNA. Since then, numerous studies have been conducted to better understand the pathophysiology and clinical manifestations of MM. ## Key Information * **Inheritance**: Mitochondrial Myopathies are inherited in a maternal lineage, meaning that the mutated mitochondrial DNA is passed from mother to child. * **Prevalence**: MM are rare disorders, affecting approximately 1 in 5,000 to 1 in 10,000 individuals. * **Symptoms**: Common symptoms include muscle weakness, fatigue, pain, vision and hearing loss, and developmental delays. * **Diagnosis**: Diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment**: There is no cure for MM, but various treatments are available to manage symptoms and slow disease progression. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. Understanding the pathophysiology of MM has led to the development of new treatments for other mitochondrial disorders, such as **Leigh Syndrome** and **NARP Syndrome**. Additionally, research on MM has shed light on the role of mitochondrial DNA in human disease, which has implications for our understanding of aging and age-related diseases. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1963 (first reported case) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, wasting, and other systemic symptoms TAGS: Mitochondrial Myopathies, rare genetic disorders, mitochondrial DNA, muscle weakness, fatigue, pain, vision and hearing loss, developmental delays, MELAS, MERRF, KSS, Kearns-Sayre Syndrome.
Health & MedicineConditions Encyclopedia Entry 1780429024
Mitochondrial myopathies are a group of rare genetic disorders characterized by muscle weakness, fatigue, and other systemic symptoms due to impaired mitochondrial function.
Health & MedicineConditions Encyclopedia Entry 1782342966
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within muscle cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. Mitochondria are the powerhouses of cells, responsible for generating energy in the form of ATP (adenosine triphosphate). In individuals with mitochondrial myopathies, the mitochondria are unable to produce sufficient energy, leading to muscle weakness, fatigue, and other systemic symptoms. These disorders can affect any muscle group, but the muscles of the face, eyes, and limbs are commonly affected. Mitochondrial myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. The symptoms of mitochondrial myopathies can vary widely, even within the same family. Some individuals may experience mild symptoms, while others may experience more severe symptoms that significantly impact their quality of life. ## History/Background The first cases of mitochondrial myopathies were described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of the mitochondrial DNA and its role in energy production revolutionized our understanding of these disorders. Since then, numerous studies have identified the genetic mutations responsible for mitochondrial myopathies and developed diagnostic tests to detect these mutations. ## Key Information Mitochondrial myopathies are classified into several subtypes, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: a subtype characterized by seizures, muscle weakness, and lactic acidosis. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: a subtype characterized by seizures, muscle weakness, and ragged-red fibers (abnormal muscle fibers) on muscle biopsy. * **Kearns-Sayre syndrome (KSS)**: a subtype characterized by progressive external ophthalmoplegia (weakness of the eye muscles), heart block, and pigmentary retinopathy. * **Leigh syndrome**: a subtype characterized by progressive brain damage, muscle weakness, and lactic acidosis. ## Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining muscle and overall health. These disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these disorders. Early diagnosis and treatment can significantly improve the quality of life for individuals with mitochondrial myopathies. INFOBOX: - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first cases described) - Location: Global (affecting individuals worldwide) - Known For: Rare genetic disorders affecting mitochondrial function TAGS: Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Lactic Acidosis, MELAS, MERRF, KSS, Leigh Syndrome, Mitochondrial DNA, Nuclear DNA.
Health & MedicineConditions Encyclopedia Entry 1781279167
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial Myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of Mitochondrial Myopathies can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial Myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. In some cases, the condition can be caused by a new mutation in the mitochondrial DNA. The diagnosis of Mitochondrial Myopathies is often challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background Mitochondrial Myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of the condition was understood. In 1988, a team of researchers led by Dr. Douglas C. Wallace discovered that Mitochondrial Myopathies were caused by mutations in the mitochondrial DNA. This discovery led to a greater understanding of the role of mitochondria in cellular energy production and the development of new treatments for the condition. ## Key Information Mitochondrial Myopathies are a group of disorders that affect the mitochondria, the energy-producing structures within cells. The most common types of Mitochondrial Myopathies include: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a condition characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle tissue. * **Kearns-Sayre Syndrome (KSS)**: a condition characterized by muscle weakness, heart problems, and vision loss. The symptoms of Mitochondrial Myopathies can vary widely, but often include: * Muscle weakness * Fatigue * Headaches * Seizures * Vision loss * Hearing loss * Heart problems ## Significance Mitochondrial Myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are often inherited and can have a significant impact on an individual's quality of life. While there is currently no cure for Mitochondrial Myopathies, various treatments are available to manage the symptoms and slow the progression of the condition. ## InfoBox: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first described), 1988 (genetic basis understood) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria ## Tags: Mitochondrial Myopathies, genetic disorder, mitochondrial DNA, autosomal dominant, maternal inheritance, MELAS, MERRF, KSS, muscle weakness, fatigue, seizures, vision loss, heart problems.